Joseph Spears - Omnicell Principal Chief Accounting Officer

OMCL Stock  USD 46.90  0.71  1.49%   

Executive

Mr. Joseph B. Spears is Vice President, Corporationrationrate Finance and Chief Accounting Officer of the company. Prior to joining Omnicell, Mr. Spears held various leadership positions in accounting and finance, including at eBay, Inc. from 2004 to 2012 as Sr. Director, Corporationrationrate Accounting. Prior to eBay, Inc., Mr. Spears held financial and accounting leadership roles at Procket Networks, Inc., Bay Networks, Inc., Nortel Networks Corporation and International Business Machines Corporationrationration. since 2018.
Age 64
Tenure 6 years
Address 4220 North Freeway, Fort Worth, TX, United States, 76137
Phone877 415 9990
Webhttps://www.omnicell.com

Joseph Spears Latest Insider Activity

Tracking and analyzing the buying and selling activities of Joseph Spears against Omnicell stock is an integral part of due diligence when investing in Omnicell. Joseph Spears insider activity provides valuable insight into whether Omnicell is net buyers or sellers over its current business cycle. Note, Omnicell insiders must abide by specific rules, including filing SEC forms every time they buy or sell Omnicell'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.

Omnicell Management Efficiency

Return On Tangible Assets is expected to rise to -0.02 this year. Return On Capital Employed is expected to rise to -0.02 this year. At this time, Omnicell's Intangible Assets are quite stable compared to the past year. Net Tangible Assets is expected to rise to about 297.7 M this year, although the value of Return On Tangible Assets are projected to rise to (0.02). Omnicell's management efficiency ratios could be used to measure how well Omnicell manages its routine affairs as well as how well it operates its assets and liabilities.
Omnicell currently holds 614.09 M in liabilities with Debt to Equity (D/E) ratio of 0.57, which is about average as compared to similar companies. Omnicell has a current ratio of 2.07, suggesting that it is liquid enough and is able to pay its financial obligations when due. Note, when we think about Omnicell's use of debt, we should always consider it together with its cash and equity.

Similar Executives

Showing other executives

EXECUTIVE Age

Jonathan WeinbergEvolent Health
53
Michael McQuiggHealthStream
56
Max KanevskyCertara
N/A
Jason HoldenForian Inc
N/A
Arthur NewmanHealthStream
75
Jessica WhiteEvolent Health
N/A
Matthew RudermanDefinitive Healthcare Corp
N/A
Christophe LouvionNational Research Corp
51
Michael JarjourCareMax
N/A
John MDEvolent Health
N/A
Daniel CorcoranCertara
N/A
Mark MannionEvolent Health
N/A
John IIICertara
51
Erick CPACareMax
45
RN BSNHealthStream
48
Rebecca AdamsForian Inc
N/A
Robert CruzEvolent Health
N/A
Kevin JDHealthStream
54
Jennifer BaronNational Research Corp
N/A
Megan CharkoNational Research Corp
N/A
Kevin OHaraHealthStream
54
Omnicell, Inc., together with its subsidiaries, provides medication management solutions and adherence tools for healthcare systems and pharmacies the United States and internationally. Omnicell, Inc. was incorporated in 1992 and is headquartered in Mountain View, California. Omnicell operates under Health Information Services classification in the United States and is traded on NASDAQ Exchange. It employs 4000 people. Omnicell (OMCL) is traded on NASDAQ Exchange in USA. It is located in 4220 North Freeway, Fort Worth, TX, United States, 76137 and employs 3,660 people. Omnicell is listed under Health Care Technology category by Fama And French industry classification.

Management Performance

Omnicell Leadership Team

Elected by the shareholders, the Omnicell's board of directors comprises two types of representatives: Omnicell inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Omnicell. The board's role is to monitor Omnicell's management team and ensure that shareholders' interests are well served. Omnicell's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Omnicell's outside directors are responsible for providing unbiased perspectives on the board's policies.
Joseph Spears, Principal Chief Accounting Officer
Kathleen Nemeth, Senior Relations
Vicki MacDevitt, Chief Staff
Sara Dalmasso, Senior International
Jorge Taborga, Executive Vice President - Engineering
Minoo Mortazavi, Senior Operations
Corey Manley, Executive Officer
David Vanella, Senior Regulatory
Roxanne Turner, Sr Officer
Nchacha Etta, Executive CFO
Randall Lipps, Executive Chairman, CEO and Pres
Scott Seidelmann, Executive Vice President and Chief Commercial Officer
Nnamdi Njoku, Executive COO
Christine Mellon, Chief VP
Peter Kuipers, CFO, Executive Vice President
Brian Nutt, Chief VP
Maximo Rocha, Senior Officer
Giri Chodavarapu, Senior Officer

Omnicell Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Omnicell a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether Omnicell is a strong investment it is important to analyze Omnicell's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Omnicell's future performance. For an informed investment choice regarding Omnicell Stock, refer to the following important reports:
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Omnicell. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.
For more information on how to buy Omnicell Stock please use our How to buy in Omnicell Stock guide.
You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.
Is Health Care Technology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Omnicell. If investors know Omnicell will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Omnicell listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
0.558
Earnings Share
(0.39)
Revenue Per Share
23.218
Quarterly Revenue Growth
(0.05)
Return On Assets
(0.01)
The market value of Omnicell is measured differently than its book value, which is the value of Omnicell that is recorded on the company's balance sheet. Investors also form their own opinion of Omnicell's value that differs from its market value or its book value, called intrinsic value, which is Omnicell's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Omnicell's market value can be influenced by many factors that don't directly affect Omnicell's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Omnicell's value and its price as these two are different measures arrived at by different means. Investors typically determine if Omnicell is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Omnicell's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.